The EIC Accelerator provides non-dilutive funding of up to €2.5M, which aligns with the venture's funding requirements. The program supports breakthrough innovations in various sectors, including biotechnology and pharmaceuticals, making it a strong fit for the venture. Additionally, the program's focus on supporting start-ups from the early research stage to scaling up aligns with the venture's current stage and goals.